Skip to main content

Full text of "USPTO Patents Application 10053526"

See other formats


/ 



EXPRBSjB MAIL CERTIFICATE 



o f/'*/" 2 - L , ^0 2 87 22 62 \0S 

I hereby certify that, on the date indicated above, this paper or fee 
was deposited with the U.S. Postal Service & that it was 
addressed for delivery to the Assistant Commissioner for Patents, 
Washington, DC 20231 by " Expre ss jg jfi— goat Office to 
Addresseei^ejpfce. 



PLEASE CHARGE ANY DEFICIENCY UP TO $300.00 OR CREDIT 
ANY EXCESS IN THE FEES DUE WITH THIS DOCUMENT TO OUR 
DEPOSIT ACCOUNT NO. 04-0100 



Name (Print) 




Signature 



Customer No. 



Docket No.: 3754/0K213 



07278 

PATENT TRADEMARK OFFICE 



IN THE UNITED STATES PATENT AND TRADEMARK OFFICE 



In re Application of: 



Marie DUTREIX; 
Rosalie MAURISSE; 



Jian-Sheng SUN; 
Jean-Paul FEUGEAS 



Elodie BIET; 



Serial No.: 10/053,526 

Confirmation No.: 1617 

Filed: January 18, 2002 

For: METHODS AND COMPOSITIONS FOR EFFECTING HOMOLOGOUS 

RECOMBINATION 



Box PATENT APPLICATION 
Assistant Commissioner for Patents 
Washington, DC 20231 

Sir: 

COMPLETION OF PATENT APPLICATION 

The following items are submitted herewith in completion of the above- 
identified patent application: 

1 . Declaration and power of attorney 

2. Payment in the amount of $ 964 . ( $ 794 filing; $ 40 recording; $130 late) 

in the form of: 
[X] check 

[] deposit account no. 04-0100 
[] credit card (see attached form) 
(See attached Fee Computation Sheet) 



3. [X] Assignment for recording to: 
INSTITUT CURIE; 

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.); 
MUSEUM NATIONAL D'HISTOIRE NATURELLE; and 

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 
(INSERM) 

4. A copy of Notice to File Missing Parts of Application. 



Priority is claimed for this application, corresponding application/s having been 
filed as follows: 

Country: Europe 
Number: 00401218.3 
Date: May 3, 2000 

The priority document [] are enclosed 

[] will follow. 

[X] was received by the International Bureau of 
WIPO on June 13, 2001. 

5. [X] Nucleotide or Amino Acid Sequence Listing. 

[X] Hard Copy [X] CRF 

The Patent Office is authorized to charge any deficiency up to $300.00 
in the above fees, and to credit any excess, to our Deposit Account No. 4-0100. 

Respectfully submitted. 



Dated: April 18, 2002 



DARBY & DARBY P.C. 
Post Office Box 5257 
New York, NY 10150-5257 
212-527-7700 



Paul F. Fehlner, Ph.D. 
Reg. No. 35,135 
Attorney for Applicant(s) 



Serial No. 10/053,526 



-2- 



Docket No. 3754/0K213 



Docket No.: 3754/0K21: 

PATENT FEE COMPUTATION SHEET 

No. of Claims Extra Claims Number of Rate 
Presented Previously Extra Claims 

Paid For 

Basic Fee $740.00 

Total Claims 23-20 -0=3 x $18.00 $54.00 

Independent 

Claims 3-3 -0 = 0 x $84.00 $0.00 

Multiple Dependent Claims - if so, add $280.00 $0.00 



Surcharge for late submission of filing fee and/or declaration $130.00 

($130.00) 

SUBTOTAL $924.00 

[] Small Entity REDUCTION (Half of Subtotal) $0.00 

Fee for recordation of assignment ($40.00) $40.00 

Charge for filing non-English language application ($130.00) $0.00 

TOTAL $964.00 



Serial No. 10/053,526 



-3- 



Docket No. 3754/0K213 





0 



Page 1 of 2 

^3 V 



I U^tee JSawrifes Patent and Trademark Office 



Commissioner for Patents 
United States Patent and Trademark Office 
Washington, D.C. 20231 
www.uspto.gov 

E 



APPLICATION NUMBER 



FILING/RECEIPT DATE 



FIRST NAMED APPLICANT 



ATTORNEY DOCKET NUMBER 



10/053,526 



01/18/2002 



Marie Dutreix 



3754/OK213 



DARBY & DARBY P.C. 
805 Third Avenue 
New York, NY 10022 



CONFIRMATION NO. 1617 
FORMALITIES LETTER 



*OC000000007661560* 



Date Mailed: 03/18/2002 



Mfl4/iMfl dam>auai ^^ C iloIQ, FILE MISSING PARTS OF NONPROVISIONAL APPLICATION 
04/24/2002 BflBRAHAl 00000013 100535ft 

01 FC:101 740.00 OP FILED UNDER 37 CFR 1 .53(b) 

02 FC:105 130.00 OP * ' 

03 FC:103 54.00 OP 

Filing Date Granted 

An application number and filing date have been accorded to this application. The item(s) indicated below, 
however, are missing. Applicant is given TWO MONTHS from the date of this Notice within which to file all 
required items and pay any fees required below to avoid abandonment. Extensions of time may be obtained by 
filing a petition accompanied by the extension fee under the provisions of 37 CFR 1.136(a). 

• The statutory basic filing fee is missing. 

Applicant must submit $ 740 to compiete the basic filing fee for a non-small entity. If appropriate, applicant 
may make a written assertion of entitlement to small entity status and pay the small entity filing fee (37 
CFR 1.27). 

• Total additional claim fee(s) for this application is $54. 

■ $54 for 3 total claims over 20. 

• The oath or declaration is unsigned. 

• To avoid abandonment, a late filing fee or oath or declaration surcharge as set forth in 37 CFR 1 .16(1) of 
$130 for a non-small entity, must be submitted with the missing items identified in this letter. 

• The balance due by applicant is $ 924. 



• This application does not contain a statement that the content of the sequence listing information recorded 
in computer readable form is identical to the written (on paper or compact disc) sequence listing and, 
where applicable, includes no new matter, as required by 37 CFR 1.821(e), 1.821(f), 1.821(g), 1.825(b), or 
1.825(d). Applicant must provide such statement. If the effective filing date is on or after September 8, 
2000, see the final rulemaking notice published in the Federal Register at 65 FR 54604 (September 8, 
2000) and 1238 OG 145 (September 19, 2000). 

• A copy of the "Sequence Listing" in computer readable form has not been submitted as required by 37 
C.F.R. 1 .821 (e). If the effective filing date is on or after September 8, 2000, see the final rulemaking notice 
published in the Federal Register at 65 FR 54604 (September 8, 2000) and 1238 OG 145 (September 19, 
2000). Applicant must provide an initial computer readable form (CRF) copy of the "Sequence Listing" and 
a statement that the content of the sequence listing information recorded in computer readable form is 
identical to the written (on paper or compact disc) sequence listing and, where applicable, includes no new 
matter, as required by 37 CFR 1 .821 (e), 1 .821 (f), 1 .821 (g), 1 .825(b), or 1 .825(d). If applicant desires the 
sequence listing in the instant application to be identical with that of another application on file in the U.S. 
Patent and Trademark Office, such request in accordance with 37 CFR 1.821(e) may be submitted in lieu 
of a new CRF. 



Page 2 of 2 



For questions regarding compliance to these requirements, please contact: 



■ For Rules Interpretation, call (703) 308-4216 

■ To Purchase Patentln Software, call (703) 306-2600 

■ For Patentln Software Program Help, call (703) 306-4119 or e-mail at 
patin21help@uspto.gov or patin3help@uspto.gov 



A copy of this notice MUST be returned with the reply. 



Customer Service Center 
Initial Patent Examination Division (703) 308-1202 

PART 3 - OFFICE COPY